END STAGE KIDNEY DISEASE
Clinical trials for END STAGE KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new END STAGE KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for END STAGE KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a tailored dialysis schedule be safer and better for kidney patients?
Disease control Recruiting nowThis study tests whether a personalized dialysis plan (adjusted to each patient's remaining kidney function) is safer and improves quality of life compared to the standard one-size-fits-all approach. About 350 adults with end-stage kidney disease who recently started dialysis wil…
Matched conditions: END STAGE KIDNEY DISEASE
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Virtual reality fights loneliness for dialysis patients
Symptom relief Recruiting nowThis study tests whether using social virtual reality (VR) during dialysis sessions can reduce loneliness and other symptoms in people with end-stage kidney disease. Sixty participants will use VR glasses for 30-45 minutes during their dialysis, three times a week for four weeks.…
Matched conditions: END STAGE KIDNEY DISEASE
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 01, 2026 15:58 UTC
-
Could a simple symptom tracker ease suffering for dialysis patients?
Symptom relief Recruiting nowThis study compares two approaches to monitoring symptoms in people receiving dialysis for kidney failure. About 2,400 adults at up to 36 U.S. clinics will either use a tablet-based symptom reporting system with clinician follow-up or receive usual care. The goal is to see if reg…
Matched conditions: END STAGE KIDNEY DISEASE
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Apr 29, 2026 15:05 UTC
-
Kidney patients needed for drug study
Knowledge-focused Recruiting nowThis study looks at how the body processes a new drug called eloralintide in people with severe kidney disease or kidney failure compared to healthy people. About 28 adults will receive a single injection under the skin. The goal is to measure drug levels in the blood and how lon…
Matched conditions: END STAGE KIDNEY DISEASE
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC